Walleye Capital’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-249,161
| Closed | -$2.88M | – | 2096 |
|
|
2025
Q1 | $2.88M | Sell |
249,161
-18,582
| -7% | -$214K | 0.01% | 511 |
|
|
2024
Q4 | $2.27M | Buy |
+267,743
| New | +$2.27M | 0.01% | 657 |
|
|
2024
Q2 | – | Sell |
-120,308
| Closed | -$1.43M | – | 2810 |
|
|
2024
Q1 | $1.43M | Buy |
120,308
+22,478
| +23% | +$267K | ﹤0.01% | 885 |
|
|
2023
Q4 | $1.2M | Buy |
97,830
+39,452
| +68% | +$483K | ﹤0.01% | 835 |
|
|
2023
Q3 | $562K | Buy |
+58,378
| New | +$562K | ﹤0.01% | 1106 |
|
|
2023
Q1 | – | Sell |
-32,482
| Closed | -$220K | – | 2445 |
|
|
2022
Q4 | $220K | Sell |
32,482
-116,385
| -78% | -$787K | ﹤0.01% | 1311 |
|
|
2022
Q3 | $2.16M | Sell |
148,867
-55,471
| -27% | -$805K | 0.04% | 424 |
|
|
2022
Q2 | $2.01M | Buy |
204,338
+140,128
| +218% | +$1.38M | 0.06% | 357 |
|
|
2022
Q1 | $946K | Buy |
+64,210
| New | +$946K | 0.03% | 643 |
|
|
2020
Q3 | – | Sell |
-16,676
| Closed | -$202K | – | 896 |
|
|
2020
Q2 | $202K | Sell |
16,676
-4,124
| -20% | -$50K | 0.05% | 433 |
|
|
2020
Q1 | $159K | Buy |
+20,800
| New | +$159K | 0.04% | 316 |
|